[1] 王海宝,刘灿,贾媛,等.DWI及动态增强MRI定量检测在前列腺癌诊断中的应用[J].蚌埠医学院学报,2016,41(9):1234.
[2] 潘云雷,张辉,李祖银,等.3.0T DCE-MRI与DW1对前列腺癌的诊断价值及与前列腺特异性抗原的相关性[J].临床医学研究,2012,47(1):1201.
[3] 白人驹,张雪林.医学影像诊断学[M].北京:人民卫生出版社,2010:472.
[4] 沈钧康,卢艳丽,杨毅.MR扩散加权成像在早期前列腺癌诊断和鉴别诊断中的应用价值[J].中华放射学杂志,2014,48(2):114.
[5] ROSENKRANTZ AB,MANNELLI L,KONG X,et al.Prostate cancer:utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization[J].J MRI,2011,34(1):95.
[6] WESTPHALEN AC,KURHARIEWICZ J,CUNHA RM,et al.T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy[J].Int Braz J Urol,2009,35(2):171.
[7] 杨晓燕,吕涵青,胡正明,等.表观扩散系数与表观扩散系数比值对前列腺癌的诊断价值与病理分级的相关性[J].中国医学影像学杂志,2016,24(8):608.
[8] TAMADA T,SONE T,JO Y,et al.Diffusion weighted MRI and its role in prostate cancer[J].NMR Biomed,2014,27(1):25.
[9] 章绪辉,全显跃,路世龙,等.DWI和ADC图在前列腺癌诊断中的应用研究[J].中国CT和MRI杂志,2014,12(8):66.
[10] UEDA Y,TAKAHASHI S,OHNO N,et al.Relationship between Gleason score and apparent diffusion coeffcients of diffusion-weighted magnetic resonance imaging in prostate cancer patients[J].Can Urol Assoc J,2016,10(11/12):E377.